Drawing for Serial No. 87664827

USPTO serial 87664827

Serial No. 87664827

Reviewed by CopyMark Law Group

Reg. 5668296Status 710
Filing date
Status date
Registration date
Feb 5, 2019
Examiner
WHEATLEY, TRAVIS DWIGHT
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with Serial No. 87664827?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David J. Davis

DAVID J. DAVIS BAKER & MCKENZIE LLP300 E. RANDOLPH STREETSUITE 5000CHICAGO, IL 60601

Goods and services

ClassDescriptionStatusFirst use
001Chemical products used in industry and science, namely, chemical ingredients for use in the manufacture of pharmaceuticalsSECTION 8 - CANCELLED—
005Pharmaceutical and veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders and for the treatment of pain, inflammation and gout and vaccines; sanitary preparations for medical purposes; dietetic substances to support nutritional balance and/or to treat deficiencies, namely, vitamins, minerals and/or probiotic cultures adapted for medical use; materials for dressings, namely, bandages, patches and tapes for dressings and adhesives to close wounds, incisions and cuts in medical and surgical proceduresSECTION 8 - CANCELLED—
009Software applications for computer and mobile devices in the field of healthcare for the purpose of monitoring patient symptoms, behavior and medicine intaking compliance, collecting and sharing health related data, enabling communication and information sharing between patients and healthcare providers; smart watches; apparatus for recording, transmission or reproduction of sound or images; blank magnetic data carriers; prerecorded magnetic data carriers containing healthcare information; data processing equipment and computers, containing and transmitting healthcare informationSECTION 8 - CANCELLED—
010Surgical and medical apparatus and instruments, namely, apparatus and instruments for use in general surgery, surgical recovery and medical examination, wearable health monitoring devices for monitoring symptoms, diseases and disorders and health-related data; medical apparatus to be used for pharmaceutical application, namely, inhalers for medical purposes sold empty, aerosol dispensers for medical use for administering functional excipients, medical syringes, pens for the administration of pharmaceutical products; sutures, medical apparatus and instruments for introducing pharmaceutical preparations into the human body, namely, infusion and injection devices for administering drugs and medicationSECTION 8 - CANCELLED—
016Printed matter, namely, books, journals, magazines and leaflets in the field of pharmacology, medicine and healthcare; photographs; instructional and teaching material in the field of pharmacology, medicine and healthcareSECTION 8 - CANCELLED—
041Conducting of training courses; issuance, publication of books, journals and other communication media in print, electronic form or otherwise, namely, book publishing and issuance of journals and scientific papers; all the aforesaid services in the medical and pharmaceutical field, especially for pharmaceutical companies, pharmacists, physicians, patients, health insurance companies and their professional associationsSECTION 8 - CANCELLED—
042Scientific and technological services and research in the medical and pharmaceutical field, namely, pharmaceutical product development, development of medical devices, development of healthcare software, development of healthcare informatics and scientific study and research services in the fields of medicine and the prevention, treatment and management of illnesses, diseases and disordersSECTION 8 - CANCELLED—
044Medical servicesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 15, 2025C8..CANCELLED SEC. 8 (6-YR)—
Feb 5, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 5, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 20, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 20, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 31, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 12, 2018PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 10, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 9, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Oct 9, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 9, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 9, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 5, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 5, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 30, 2018ALIEASSIGNED TO LIE—
Aug 15, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 16, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 16, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 16, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 8, 2018DOCKASSIGNED TO EXAMINER—
Nov 8, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Nov 7, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 2, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance